Skip to main content
. 2024 Jan 17;229(6):1614–1627. doi: 10.1093/infdis/jiad605

Table 5.

Situated Vulnerability-Related Correlates of Bacterial STI Prevalence by HIV Status

Outcome: ≥1 Bacterial STI
TGW Without HIV TGW With HIV
Situated Vulnerabilities No. Prevalence,
No. (%)
Crude
PR (95% CI)a
Adjusted
PR (95% CI)a,b
No. Prevalence,
No. (%)
Crude
PR (95% CI)a
Adjusted
PR (95% CI)a,b
AUDIT-C
 Score < 4 485 44 (9) Ref Ref 196 69 (35) Ref Ref
 Score ≥ 4 232 32 (14) 1.52 (.99–2.33) 1.64 (1.08–2.47) 66 14 (21) 0.60 (.36–.997) 0.57 (.35–.93)
Psychological violence
 Never 131 25 (19) Ref Ref 92 36 (39) Ref Ref
 Ever 602 54 (9) 0.47 (.30–.73) 0.71 (.46–1.10) 172 49 (28) 0.73 (.51–1.03) 0.74 (.53–1.05)
Physical violence
 Never 268 33 (12) Ref Ref 110 44 (40) Ref Ref
 Ever 463 45 (10) 0.79 (.52–1.21) 1.01 (.67–1.54) 151 40 (26) 0.66 (.47–.94) 0.70 (.50–.996)
Sexual violence
 Never 408 46 (11) Ref Ref 151 60 (40) Ref Ref
 Ever 321 33 (10) 0.91 (.60–1.39) 1.03 (.69–1.55) 110 24 (22) 0.55 (.37–.82) 0.59 (.40–.89)
Sex work
 Never 408 30 (7) Ref Ref 76 23 (30) Ref Ref
 Ever 324 49 (15) 2.06 (1.34–3.16) 1.55 (.995–2.41) 189 62 (33) 1.08 (.73–1.61) 1.06 (.71–1.58)
Incarceration history
 Never 575 52 (9) Ref Ref 130 43 (33) Ref Ref
 Ever 143 23 (16) 1.78 (1.13–2.81) 1.24 (.76–2.02) 130 39 (30) .91 (.63–1.30) 0.88 (.61–1.26)
Homelessness
 Never 397 35 (9) Ref Ref 102 32 (31) Ref Ref
 Ever, ≥3 mo ago 247 27 (11) 1.24 (.77–2.00) 1.07 (.67–1.71) 118 35 (30) 0.95 (.63–1.41) 0.95 (.64–1.42)
 Ever, <3 mo ago 83 16 (19) 2.19 (1.27–3.76) 1.63 (1.01–2.64) 48 16 (33) 1.06 (.65–1.74) 0.95 (.58–1.55)
Health insurance
 Insured 660 65 (10) Ref Ref 255 80 (31) Ref Ref
 Uninsured 75 14 (19) 1.90 (1.12–3.21) 1.57 (.93–2.65) 11 5 (45) 1.45 (.74–2.84) 1.28 (.70–2.36)
Safety concern in transit to health care
 No 433 35 (8) Ref Ref 132 43 (33) Ref Ref
 Yes 304 44 (14) 1.79 (1.18–2.72) 1.68 (1.11–2.54) 140 44 (31) 0.96 (.68–1.37) 0.85 (.60–1.19)
Gender identity therapy or counseling
 Never 191 38 (20) Ref Ref 91 32 (35) Ref Ref
 Former, ≥3 mo ago 226 15 (7) 0.33 (.19–.59) 0.45 (.26–.79) 73 21 (29) 0.82 (.52–1.29) 0.91 (.58–1.41)
 Current, <3 mo ago 318 25 (8) 0.40 (.25–.63) 0.52 (.33–.83) 100 29 (29) 0.82 (.54–1.25) 0.84 (.56–1.25)
Hormone treatment use
 Never 82 15 (18) Ref Ref 62 17 (27) Ref Ref
 Former, ≥3 mo ago 44 9 (20) 1.12 (.53–2.35) 1.28 (.63–2.63) 30 14 (47) 1.70 (.97–2.97) 1.70 (.99–2.91)
 Current, <3 mo ago, 609 54 (9) 0.48 (.29–.82) 0.67 (.40–1.11) 174 52 (30) 1.09 (.68–1.74) 1.14 (.73–1.79)
Genital surgeryc
 Never 612 72 (12) Ref Ref 232 73 (31) Ref Ref
 Ever 111 4 (4) 0.31 (.11–.82) 0.34 (.13–.89) 30 9 (30) 0.95 (.53–1.70) 1.19 (.66–2.14)
Engagement in HIV care, 12 mo
 No 34 9 (26) 0.79 (.44–1.44) .72 (.42–1.25)
 Yes 207 69 (33) Ref Ref

Abbreviations: AUDIT-C, Alcohol Use Disorder Identification Test-Consumption; CI, confidence interval; HIV, human immunodeficiency virus; PR, prevalence ratio; Ref, reference; STI, sexually transmitted infection; TGW, transgender women.

aPRs were estimated using Poisson regression models with robust variance estimation.

bFor each STI outcome variable, a separate multivariable regression model was used that adjusted for age, race and ethnicity, and geographic region.

cVaginoplasty or orchiectomy.